Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125515381 | 12551538 | 1 | I | 20160630 | 20160713 | 20160713 | EXP | US-DRREDDYS-USA/USA/16/0081391 | DR REDDYS | BUTTAR R, KREIMERMAN J, ALETA M, MELAMED M. RHABDOMYOLYSIS AND ACUTE KIDNEY INJURY PRECIPITATED BY A POSSIBLE SITAGLIPTIN-ATORVASTATIN DRUG INTERACTION. AM J KIDNEY DIS. 2016;67(5):A31. | 86.00 | YR | F | Y | 0.00000 | 20160713 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125515381 | 12551538 | 1 | PS | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | UNKNOWN | 91650 | 20 | MG | QD | ||||||
| 125515381 | 12551538 | 2 | I | SITAGLIPTIN | SITAGLIPTIN | 1 | Unknown | Y | 0 | 100 | MG | QD | |||||||
| 125515381 | 12551538 | 3 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 4 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 6 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 7 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 8 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | Y | 0 | ||||||||||
| 125515381 | 12551538 | 9 | C | GINKGO BILOBA | GINKGO | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125515381 | 12551538 | 1 | Product used for unknown indication |
| 125515381 | 12551538 | 2 | Type 2 diabetes mellitus |
| 125515381 | 12551538 | 3 | Product used for unknown indication |
| 125515381 | 12551538 | 4 | Product used for unknown indication |
| 125515381 | 12551538 | 5 | Product used for unknown indication |
| 125515381 | 12551538 | 6 | Product used for unknown indication |
| 125515381 | 12551538 | 7 | Product used for unknown indication |
| 125515381 | 12551538 | 8 | Product used for unknown indication |
| 125515381 | 12551538 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125515381 | 12551538 | OT |
| 125515381 | 12551538 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125515381 | 12551538 | Acute kidney injury | |
| 125515381 | 12551538 | Drug interaction | |
| 125515381 | 12551538 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |